Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription elongation factor A like 6 (TCEAL6) is a member of the TCEAL gene family, which encodes proteins related to transcriptional elongation factor SII (TFIIS/SII) and is involved in the regulation of RNA polymerase II transcriptional activity[7][9]. The exact function of TCEAL6 remains unclear, but it is predicted to contribute to nuclear transcriptional regulation, potentially by modulating transcript elongation and processing steps. TCEAL6 is localized to the nucleus and its gene is found on the X chromosome (X:102,140,476-102,142,970)[6][7]. The protein is not currently implicated as a direct target for drug intervention, nor is it a clinically established biomarker. Its role in disease remains under investigation, with limited evidence for correlative expression changes in certain cancers[3][7].
None. There are no drugs targeting this molecule, so no mechanisms of drug action are reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription elongation factor A like 6 (TCEAL6).